FDA Inspection 1342062 — Department Of Defense - Air Force 374Th Medical Group

Department Of Defense - Air Force 374Th Medical Group — FEI 3002809399

The FDA completed an inspection of Department Of Defense - Air Force 374Th Medical Group on Sep 22, 2026 in Apo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 22, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Apo (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.